US2010152117A1PendingUtilityA1

Aequorin-Containing Compositions and Methods of Using Same

Assignee: QUINCY BIOSCIENCE LLCPriority: Jun 21, 2004Filed: Jan 27, 2010Published: Jun 17, 2010
Est. expiryJun 21, 2024(expired)· nominal 20-yr term from priority
A61P 9/10A61P 39/06A61P 43/00A61P 37/04A61P 37/02A61P 5/00A61P 25/28A61P 31/12A61P 35/00A61P 3/14A61P 25/00A61P 3/00A61P 21/00A61P 19/08A61K 38/17
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions containing aequorin and methods for their use in preventing and/or alleviating symptoms and disorders related to calcium imbalance are provided by the present invention.

Claims

exact text as granted — not AI-modified
1 . A composition for preventing or alleviating a symptom or disorder associated with calcium imbalance comprising:
 (a) an effective amount of aequorin; and   (b) an acceptable carrier.   
   
   
       2 . The composition according to  claim 1  further comprising an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, anti-viral agent, or a mixture thereof. 
   
   
       3 . The composition according to  claim 1 , wherein said composition is in a unit dosage form selected from the group consisting of a tablet, a capsule, a solution, a suspension, a syrup, a beverage, an oral or ophthalmic formulation and an injection. 
   
   
       4 . A method for preventing or alleviating a symptom or disorder associated with calcium imbalance comprising administering to a subject in need of such treatment an effective amount of aequorin. 
   
   
       5 . The method according to  claim 4  wherein the symptom or disorder associated with calcium imbalance is related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion or bone mineralization. 
   
   
       6 . The method according to  claim 4  wherein the symptom or disorder is caused by ischemia. 
   
   
       7 . The method according to  claim 4 , wherein said effective amount of aequorin is provided in combination with an immune boosting agent, anti-inflammatory agent, anti-oxidant agent, anti-viral agent, or a mixture thereof. 
   
   
       8 . The method according to  claim 4  wherein said effective amount of aequorin is in a unit dosage form selected from the group consisting of a tablet, a capsule, a solution, a suspension, a syrup, a beverage, an oral or ophthalmic formulation and an injection.

Join the waitlist — get patent alerts

Track US2010152117A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.